Sectors
BCAX
Bicara Therapeutics Inc.
23.12
2 x 18.74
2 x 32.75
bid
ask
-
0.31
1.32%
2 @ 07:30 PM
23.12 +0.00 (0.00%)
| Ytd | 37.37% | |
| 1y | 93.63% |
22.61
day range
23.50
10.29
52 week range
30.99
| Open | 23.36 | Prev Close | 23.43 | Low | 22.61 | High | 23.50 | Mkt Cap | 1.53B |
| Vol | 511.97K | Avg Vol | 727.66K | EPS | -3.07 | P/E | N/A | Forward P/E | -6.73 |
| Beta | -0.75 | Short Ratio | 17.09 | Inst. Own | 107.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 26.60 | 200-d Avg | 20.80 | 1yr Est | 33.50 |
| Income Statement | |||
| Operating Expenses | 59.95M | ||
| Research and Development Expense | 45.77M | ||
| Selling, General and Administrative Expense | 14.18M | ||
| Operating Income | -59.95M | ||
| Income Tax Expense | 61.00K | ||
| Net Income | -55.44M | ||
| Net Income Common Stock | -55.44M | ||
| Net Income Common Stock (USD) | -55.44M | ||
| Consolidated Income | -55.44M | ||
| Earnings per Basic Share | -0.82 | ||
| Earnings per Basic Share (USD) | -0.82 | ||
| Earnings per Diluted Share | -0.82 | ||
| Earning Before Interest & Taxes (EBIT) | -55.37M | ||
| Earning Before Interest & Taxes (USD) | -55.37M | ||
| Weighted Average Shares | 67.93M | ||
| Weighted Average Shares Diluted | 67.93M | ||
| Balance Sheet | |||
| Cash and Equivalents | 96.60M | ||
| Cash and Equivalents (USD) | 96.60M | ||
| Investments | 400.66M | ||
| Investments Current | 400.66M | ||
| Current Assets | 503.82M | ||
| Property, Plant & Equipment Net | 1.51M | ||
| Total Assets | 512.24M | ||
| Debt Current | 1.16M | ||
| Total Debt | 1.16M | ||
| Current Liabilities | 43.48M | ||
| Total Liabilities | 43.48M | ||
| Accumulated Retained Earnings (Deficit) | -470.61M | ||
| Accumulated Other Comprehensive Income | -567.00K | ||
| Shareholders Equity | 468.77M | ||
| Shareholders Equity (USD) | 468.77M | ||
| Assets Non-Current | 8.42M | ||
| Total Debt (USD) | 1.16M | ||
| Trade and Non-Trade Payables | 8.46M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 321.00K | ||
| Net Cash Flow from Financing | 2.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -226.86M | ||
| Capital Expenditure | -60.00K | ||
| Issuance (Purchase) of Equity Shares | 2.33M | ||
| Net Cash Flow from Investing | -184.99M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -184.93M | ||
| Net Cash Flow from Operations | -44.21M | ||
| Share Based Compensation | 8.24M | ||